Latest News and Press Releases
Want to stay updated on the latest news?
-
WEST BRIDGEWATER, Mass., March 9, 2007 (PRIME NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) Grant...
-
WILMINGTON, Del., March 6, 2007 (PRIME NEWSWIRE) -- Third-Order Nanotechnologies, Inc. (Pink Sheets:TDON) announced today that Terry Turpin (Director, Senior Vice President and Chief Technology...
-
SUNNYVALE, CA -- (MARKET WIRE) -- March 1, 2007 --Finisar Corporation (NASDAQ: FNSR), a technology leader in fiber optic and test-and-measurement solutions for high-speed data networks, today...
-
ALAMEDA, Calif., Feb. 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of neurological conditions, announced today...
-
- Annual Accounts for the year 2006 " The consolidated profit of Milestone in the year 2006 amounted to ISK 21.4 billion net of taxes. " Return of equity at year-end was 92%. " Total assets at...
-
ELMWOOD PARK, N.J., Feb. 22, 2007 (PRIME NEWSWIRE) -- The Food Institute, a nonprofit organization devoted to providing information to the food industry, and iLumen, Inc., today jointly announced a...
-
ATLANTA, Feb. 20, 2007 (PRIME NEWSWIRE) -- As part of a new strategic partnership with Synapse Technology, Harland Financial Solutions will offer the SynapseEBM Pattern Evaluator Engine as part of its...
-
BASEL, Switzerland, Feb. 19, 2007 (PRIME NEWSWIRE) -- Basilea Pharmaceutica Ltd. (SWX:BSLN) announced today that its placebo-controlled pivotal phase III BACH trial (Benefit of Alitretinoin in Chronic...
-
Basel, Switzerland, February 19, 2007 - Basilea Pharmaceutica Ltd. (SWX:BSLN) announced today that its placebo-controlled pivotal phase III BACH trial (Benefit of Alitretinoin in Chronic Hand...
-
MOUNTAIN VIEW, CA -- (MARKET WIRE) -- February 12, 2007 -- -- Support and services revenue up 21% from the comparable year-ago quarter -- Hosting revenue up 19% from the comparable year-ago...